短段与长段巴雷特食管进展为食管腺癌的年进展率较低
该研究纳入7家三级转诊中心1883例非异型增生巴雷特食管(NDBE)患者,中位随访6.4年。短段BE(SSBE)进展为食管腺癌(EAC)的年进展率0.07%显著低于长段BE(LSBE)的0.25%(P=.001),多因素分析风险比0.32(95%CI 0.18-0.57;P<.001)。作者提出延长SSBE患者的监测间隔。
要点
- SSBE进展为EAC年率0.07%,低于LSBE的0.25%(P=.001)。
- SSBE进展为HGD或EAC年率0.29%,低于LSBE的0.91%(P<.001)。
- 多因素分析风险比0.32(95%CI 0.18-0.57;P<.001)。
核心结论
- SSBE进展为EAC的年率0.07%/年低于LSBE的0.25%/年,作者提出延长SSBE患者的监测间隔。
研究设计与样本
- 多中心队列研究,纳入7家三级转诊中心1883例内镜证实的NDBE患者,平均年龄57.3岁,83.5%男性,88.1%白人,中位随访6.4年。
主要发现
- SSBE患者822例,LSBE患者1061例。
- SSBE进展为EAC的年率0.07%显著低于LSBE的0.25%(P=.001)。
- SSBE进展为HGD或EAC的年率0.29%显著低于LSBE的0.91%(P<.001)。
- 多因素分析中,SSBE与LSBE相比进展风险比为0.32(95%CI 0.18-0.57;P<.001)。
关键数值与推荐
- 短段BE定义为长度≥1且<3 cm,长段BE定义为长度≥3 cm。
- 索引内镜检查后1年内检出的异型增生或EAC被视为 prevalent 并排除。
临床怎么用
- 作者提出延长当前SSBE患者的监测间隔。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: European guidelines recommend different surveillance intervals of non-dysplastic Barrett's esophagus (NDBE) based on segment length, as opposed to guidelines in the United States, which do recommend surveillance intervals based on BE length. We studied rates of progression of NDBE to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) in patients with short-segment BE using the definition of BE in the latest guidelines (length ≥1 cm). METHODS: We collected demographic, clinical, endoscopy, and histopathology data from 1883 patients with endoscopic evidence of NDBE (mean age, 57.3 years; 83.5% male; 88.1% Caucasians) seen at 7 tertiary referral centers. Patients were followed for a median 6.4 years. Cases of dysplasia or EAC detected within 1 year of index endoscopy were considered prevalent and were excluded. Unadjusted rates of progression to HGD or EAC were compared between patients with short (≥1 and <3) and long (≥3) BE lengths using log-rank tests. A subgroup analysis was performed on patients with a documented Prague C&M classification. We used a multivariable proportional hazards model to evaluate the association between BE length and progression. Adjusted hazards ratios were calculated after adjusting for variables associated with progression. RESULTS: We found 822 patients to have a short-segment BE (SSBE) and 1061 to have long segment BE (LSBE). We found patients with SSBE to have a significantly lower annual rate of progression to EAC (0.07%) than of patients with LSBE (0.25%) (P = .001). For the combined endpoint of HGD or EAC, annual progression rates were significantly lower among patients with SSBE (0.29%) compared to compared to LSBE (0.91%) (P < .001). This effect persisted in multivariable analysis (hazard ratio, 0.32; 95% CI, 0.18-0.57; P < .001). CONCLUSION: We analyzed progression of BE (length ≥1 cm) to HGD or EAC in a large cohort of patients seen at multiple centers and followed for a median 6.4 years. We found a lower annual rate of progression of SSBE to EAC (0.07%/year) than of LSBE (0.25%/year). We propose lengthening current surveillance intervals for patients with SSBE.
引用
- Hamade N, Vennelaganti S, Parasa S, et al. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2018. PMID: 30012433. doi:10.1016/j.cgh.2018.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。